Cite

HARVARD Citation

    Toffalorio, F. et al. (2014). Phase Ib of Sorafenib in Combination With Everolimus in Patients With Advanced Solid Tumors, Selected on the Basis of Molecular Targets. Oncologist. pp. 344-345. [Online]. 
  
Back to record